Surgical Science Sweden AB (publ)
SUSRF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $8 | $6 | $9 | $12 |
| - Cash | $1 | $1 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $7 | $5 | $8 | $12 |
| Revenue | $1 | $1 | $1 | $0 |
| % Growth | 0.1% | 10% | 118.8% | – |
| Gross Profit | $1 | $1 | $1 | $0 |
| % Margin | 67.6% | 69.4% | 66.2% | 72.5% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 19.2% | 24.3% | 33.8% | 31.4% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 14.9% | 26.5% | 23.4% | 23.5% |
| EPS Diluted | 2.58 | 4.59 | 3.69 | 2.02 |
| % Growth | -43.8% | 24.4% | 82.7% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |